| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/07/2007 | CA2632094A1 Carbonic anhydrase ix (g250) antibodies and methods of use thereof |
| 06/07/2007 | CA2629227A1 Precursor compound of radioactive halogen-labeled organic compound |
| 06/07/2007 | CA2629143A1 Multimeric magentic resonance contrast agents |
| 06/07/2007 | CA2628539A1 Method of dynamic nuclear polarisation (dnp) using a trityl radical and a paramagnetic metal ion |
| 06/06/2007 | EP1792894A2 Contrast agents |
| 06/06/2007 | EP1792187A1 Compounds and methods for combined optical-ultrasound imaging |
| 06/06/2007 | EP1791570A1 Superparamagnetic gadolinium oxide nanoscale particles and compositions comprising such particles |
| 06/06/2007 | EP1791569A1 Improved selection of-ph dependent compounds for in vivo therapy |
| 06/06/2007 | EP1284146B1 Liposomes containing hydrophobic iodo compound |
| 06/06/2007 | EP0742723B1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 06/06/2007 | DE102006056869A1 Flexible pipe for inserting endoscope into duodenum, small- and large intestine to examine gastro-intestinal tract, has flexible tubing section and bendable section, whose proximal end is coupled with distal end of flexible tubing section |
| 06/06/2007 | CN1976728A Contrast agents for myocardial perfusion imaging. |
| 06/06/2007 | CN1976720A Compositions and methods for treatment of severe acute respiratory syndrome (SARS) |
| 06/06/2007 | CN1973832A Biodegradable nanometer medicine capsule with CT trace effect and its prepn process |
| 06/05/2007 | US7226578 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis |
| 06/05/2007 | US7226577 Gastrin releasing peptide compounds |
| 05/31/2007 | WO2007061768A2 Fluorescent membrane intercalating probes and methods for their use |
| 05/31/2007 | WO2007061036A1 Contrast medium using fullerene derivative |
| 05/31/2007 | WO2007028037A8 Biocompatible n, n-disubstituted sulfonamide-containing fluorescent dye labels |
| 05/31/2007 | WO2007006041A3 Imaging and therapeutic method using monocytes |
| 05/31/2007 | WO2006099516A3 Methods for magnetic resonance imaging |
| 05/31/2007 | WO2006074272A3 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| 05/31/2007 | WO2005089106A3 Degradable nanoparticles |
| 05/31/2007 | WO2005017484A3 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors |
| 05/31/2007 | US20070124171 System and method for universal medication identification |
| 05/31/2007 | US20070123699 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 05/31/2007 | US20070122851 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 05/31/2007 | US20070122403 Molecules with extended half-lives, compositions and uses thereof |
| 05/31/2007 | US20070122348 For preventing oral abuse of an oral opioid formulation; provides a negative, "aversive" experience when a large amount of the opioid, e.g., about 2-3 times the usually prescribed dose, is taken by or administered to a physically dependent subject |
| 05/31/2007 | US20070122346 Conjugated macromolecules |
| 05/31/2007 | US20070122345 Intraoperative determination of nerve location |
| 05/31/2007 | US20070122344 Intraoperative determination of nerve location |
| 05/31/2007 | US20070122343 Non-invasive assay for the assessment of functioning and/or structure of the gut |
| 05/31/2007 | US20070122340 Necrosis avid tracer agent |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790642A1 Biologically active methylene blue derivatives |
| 05/30/2007 | EP1789361A1 Water-soluble nanoparticles stabilized with multi-functional group ligands and method of preapation thereof |
| 05/30/2007 | EP1789097A2 Radiopaque polymeric stents |
| 05/30/2007 | EP1789032A2 Use of thyroid hormone conversion inhibitors |
| 05/30/2007 | EP1582539B1 Latex polymer particles containing fluorescent substance or contrast medium and process for producing the same |
| 05/30/2007 | EP1536785B1 Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
| 05/30/2007 | CN1973199A Method of determining performance of an antiperspirant compositions |
| 05/30/2007 | CN1973029A Nanofibrillar structure and applications including cell and tissue culture |
| 05/30/2007 | CN1318388C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 05/30/2007 | CN1318094C Magnetic resonance radiography reinforcing coating composition used for interposing catheter or device and its preparation method |
| 05/29/2007 | US7223380 Administering a radionuclide-labeled bis-aminoethanethiol (BAT) dicarboxylic acid-targeting ligand conjugate, which is a folate receptor targeting ligand, an agent that mimics glucose, annexin V, colchicine, glutamate pentapeptide, or a tumor hypoxia targeting ligand |
| 05/29/2007 | CA2154867C Gas mixtures useful as ultrasound contrast media |
| 05/24/2007 | WO2007057901A2 Method and apparatus utilizing animals for detecting target substances |
| 05/24/2007 | WO2007056961A1 An optimized relaxivity and specificity hepatobiliary mri contrast agent |
| 05/24/2007 | WO2007028163A8 Biocompatible fluorescent imaging agents |
| 05/24/2007 | WO2007020450A3 Imaging agent comprising iron containing colloidal particle conjugated to oligosaccharides |
| 05/24/2007 | WO2006125105A3 Methods and compositions for treating and diagnosing multiple sclerosis |
| 05/24/2007 | WO2006102611A3 Therapeutic agents for the treatment of leukemia |
| 05/24/2007 | WO2006089122A3 De novo synthesis of bacteriochlorins |
| 05/24/2007 | US20070116648 Optimized relaxivity and specificity hepatobiliary MRI contrast agent |
| 05/24/2007 | US20070116647 Medicinal preparation particularly for the treatment of slipped discs hernias |
| 05/24/2007 | US20070116646 Optical imaging of endometriosis |
| 05/24/2007 | US20070116645 Methods and compositions for inhibiting cholesterol uptake |
| 05/24/2007 | CA2635496A1 Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts |
| 05/24/2007 | CA2628678A1 Fluorescent nanoparticles |
| 05/23/2007 | EP1787661A1 Medicinal preparation |
| 05/23/2007 | EP1786904A2 Adenoviral vector compositions |
| 05/23/2007 | EP1786477A2 Method of preselection patients for anti-vegf, anti-hif-1 or anti-thioredoxin therapy |
| 05/23/2007 | EP1786476A1 Method of detecting and treating allogenic cells responsible for endometriosis |
| 05/23/2007 | EP1786475A2 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 05/23/2007 | EP1786465A2 Methods for detecting and treating autoimmune disorders |
| 05/23/2007 | EP1417183B1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 05/23/2007 | EP1212619B1 Substrates and screening methods for transport proteins |
| 05/23/2007 | EP1140203B1 Vitronectin receptor antagonist pharmaceuticals |
| 05/23/2007 | CN1969190A Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 05/23/2007 | CN1968705A Carboranylporphyrins and uses thereof |
| 05/23/2007 | CN1967248A Biological functional fluorescence magnetic particle and its preparing method and application |
| 05/23/2007 | CN1966088A Magnetic resonance imaging contrast using arabinogalactan as carrier |
| 05/23/2007 | CN1966087A Method for constructing primary liver cancer model of mice |
| 05/23/2007 | CN1966086A Method for obtaining alimentary absorption characteristic of medicament |
| 05/23/2007 | CN1966085A A novel gadodiamide-EDTA composite injection and method for preparing same |
| 05/23/2007 | CN1317303C Anti-human tenascin monoclonal antibody |
| 05/23/2007 | CN1317037C Magnetic resonance tumour target contrast media and preparing method thereof |
| 05/23/2007 | CN1317036C Method of thalidomide for effective intervening oral cancer in animal model |
| 05/22/2007 | US7220890 Chimeric mouse model for endometriosis |
| 05/22/2007 | US7220862 Calcitonin gene related peptide receptor antagonists |
| 05/22/2007 | US7220840 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 05/22/2007 | US7220827 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 05/22/2007 | US7220723 Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| 05/22/2007 | US7220425 Method for therapy of liver tumors |
| 05/22/2007 | US7220401 To deliver a radionuclide to a blood clot, to obtain an ultrasound image of a blood clot, for diagnosis, therapy |
| 05/22/2007 | CA2237983C Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/22/2007 | CA2187353C Liquid delivery compositions |
| 05/18/2007 | WO2007055995A2 Nanoparticle-based imaging agents for x-ray/computed tomography |
| 05/18/2007 | WO2007055580A1 Contrast agents and diagnostic compositions based on iodine-containing cyanuric acid derivatives |
| 05/18/2007 | WO2007054182A2 Nanoparticles used as contrasting agents in magnetic resonance imaging |
| 05/18/2007 | WO2007003944A3 Compounds for imaging and therapy |
| 05/18/2007 | WO2006106544A3 Use of nothobranchius furzeri as a model system for the characterization of drugs that control ageing |
| 05/18/2007 | WO2006079119A9 Modulation of th2 lineage commitment by t-bet |
| 05/18/2007 | WO2005113021A3 Device, system and method for in-vivo analysis |
| 05/17/2007 | US20070113298 Genetically determined mouse model of resistance to transplantable cancers |
| 05/17/2007 | US20070112061 Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound |
| 05/17/2007 | US20070111946 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 05/17/2007 | US20070111020 Chemical reduction process to form magnetic metal core, sulfiding to form metal sulfide seed crystal, coating a fluorescent semiconductor material on sulfide surface; biosensors with optical and magnetical activities, visual detection of a test strip |
| 05/17/2007 | US20070110766 Proteinase K resistant surface protein of neisseria meningitidis |